Neurobiology of adult and teenage suicide

Asian Journal of Psychiatry

Volumn 4, Issue 1, 2011, Pages 2-13

  Pandey, Ghanshyam N ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

BDNF; Cellular signaling; Cytokines; HPA axis; Serotonin; Suicide

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYTOKINE; GUANINE NUCLEOTIDE BINDING PROTEIN; NORADRENALIN; PHOSPHOLIPASE C; PROTEIN TRK B; PROTEIN TYROSINE KINASE; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR; UNCLASSIFIED DRUG;

HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NEUROBIOLOGY; NEUROIMAGING; PRIORITY JOURNAL; REVIEW; SUICIDAL BEHAVIOR; SUICIDE;

EID: 79952625192     PISSN: 18762018     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajp.2011.01.008     Document Type: Review

References (188)

1. Aderem A. The MARCKS brothers: a family of protein kinase C substrates. Cell 1992, 71:713-716.
2. Agren H. Symptom patterns in unipolar and bipolar depression correlating with monoamine metabolites in the cerebrospinal fluid: I. General patterns. Psychiatry Res. 1980, 3:211-223.
3. Agren H., Niklasson F. Suicidal potential in depression: focus on CSF monoamine and purine metabolites. Psychopharmacol. Bull. 1986, 22:656-660.
4. Akimoto K., Mizuno K., Osada S., Hirai S., Tanuma S., Suzuki K., et al. A new member of the third class in the protein kinase C family, PKC lambda, expressed dominantly in an undifferentiated mouse embryonal carcinoma cell line and also in many tissues and cells. J. Biol. Chem. 1994, 269:12677-12683.
5. Altar C.A., Cai N., Bliven T., Juhasz M., Conner J.M., Acheson A.L., et al. Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature 1997, 389:856-860.
6. Anderson D., Koch C.A., Grey L., Ellis C., Moran M.F., Pawson T. Binding of SH2 domains of phospholipase C gamma 1, GAP, and Src to activated growth factor receptors. Science 1990, 250:979-982.
7. Anisman H., Kokkinidis L., Merali Z. Further evidence for the depressive effects of cytokines: anhedonia and neurochemical changes. Brain Behav. Immun. 2002, 16:544-556.
8. Apter A., Brown S., Kom M., Van Praag H.M. Serotonin in childhood psychopathology. Serotonin in Psychiatry 1990, Bruner Mazel, New York. S. Brown, H.M. Van Praag (Eds.).
9. Apter A., Gothelf D., Orbach I., Weizman R., Ratzoni G., Har-Even D., et al. Correlation of suicidal and violent behavior in different diagnostic categories in hospitalized adolescent patients. J. Am. Acad. Child Adolesc. Psychiatry 1995, 34:912-918.
10. Arango V., Ernsberger P., Marzuk P.M., Chen J.S., Tierney H., Stanley M., et al. Autoradiographic demonstration of increased serotonin 5-HT2 and beta-adrenergic receptor binding sites in the brain of suicide victims. Arch. Gen. Psychiatry 1990, 47:1038-1047.
11. Arango V., Underwood M.D., Boldrini M., Tamir H., Kassir S.A., Hsiung S., et al. Serotonin 1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims. Neuropsychopharmacology 2001, 25:892-903.
12. Arango V., Underwood M.D., Gubbi A.V., Mann J.J. Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Res. 1995, 688:121-133.
13. Arango V., Underwood M.D., Mann J.J. Fewer pigmented locus coeruleus neurons in suicide victims: preliminary results. Biol. Psychiatry 1996, 39:112-120.
14. Arranz B., Eriksson A., Mellerup E., Plenge P., Marcusson J. Brain 5-HT1A, 5-HT1D, and 5-HT2 receptors in suicide victims. Biol. Psychiatry 1994, 35:457-463.
15. Asberg M., Bertilsson L., Martensson B., Scalia-Tomba G.P., Thoren P., Traskman-Bendz L. CSF monoamine metabolites in melancholia. Acta Psychiatr. Scand. 1984, 69:201-219.
16. Asberg M., Traskman L., Thoren P. 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor?. Arch. Gen. Psychiatry 1976, 33:1193-1197.
17. Audenaert K., Van Laere K., Dumont F., Slegers G., Mertens J., van Heeringen C., et al. Decreased frontal serotonin 5-HT 2a receptor binding index in deliberate self-harm patients. Eur. J. Nucl. Med. 2001, 28:175-182.
18. Baldassare J.J., Henderson P.A., Burns D., Loomis C., Fisher G.J. Translocation of protein kinase C isozymes in thrombin-stimulated human platelets. Correlation with 1,2-diacylglycerol levels. J. Biol. Chem. 1992, 267:15585-15590.
19. Barbacid M. The Trk family of neurotrophin receptors. J. Neurobiol. 1994, 25:1386-1403.
20. Bartrup J.T., Moorman J.M., Newberry N.R. BDNF enhances neuronal growth and synaptic activity in hippocampal cell cultures. Neuroreport 1997, 8:3791-3794.
21. Baumann B., Danos P., Diekmann S., Krell D., Bielau H., Geretsegger C., et al. Tyrosine hydroxylase immunoreactivity in the locus coeruleus is reduced in depressed non-suicidal patients but normal in depressed suicide patients. Eur. Arch. Psychiatry Clin. Neurosci. 1999, 249:212-219.
22. Beck A.T., Steer R.A., Beck J.S., Newman C.F. Hopelessness, depression, suicidal ideation, and clinical diagnosis of depression. Suicide Life Threat. Behav. 1993, 23:139-145.
23. Biegon A., Fieldust S. Reduced tyrosine hydroxylase immunoreactivity in locus coeruleus of suicide victims. Synapse 1992, 10:79-82.
24. Birnbaumer L., Abramowitz J., Yatani A., Okabe K., Mattera R., Graf R., et al. Roles of G proteins in coupling of receptors to ionic channels and other effector systems. Crit. Rev. Biochem. Mol. Biol. 1990, 25:225-244.
25. Blackshear P.J. The MARCKS family of cellular protein kinase C substrates. J. Biol. Chem. 1993, 268:1501-1504.
26. Botsis A.F., Soldatos C.R, C.N S. Suicide: Biopsychosocial Approaches 1997, Elsevier, Amsterdam.
27. Brent D.A., Baugher M., Bridge J., Chen T., Chiappetta L. Age- and sex-related risk factors for adolescent suicide. J. Am. Acad. Child Adolesc. Psychiatry 1999, 38:1497-1505.
28. Brent D.A., Kolko D.J., Wartella M.E., Boylan M.B., Moritz G., Baugher M., et al. Adolescent psychiatric inpatients' risk of suicide attempt at 6-month follow-up. J. Am. Acad. Child Adolesc. Psychiatry 1993, 32:95-105.
29. Brown G.L., Goodwin F.K., Ballenger J.C., Goyer P.F., Major L.F. Aggression in humans correlates with cerebrospinal fluid amine metabolites. Psychiatry Res. 1979, 1:131-139.
30. Brown N.A., McAllister G., Weinberg D., Milligan G., Seabrook G.R. Involvement of G-protein alpha il subunits in activation of G-protein gated inward rectifying K+ channels (GIRK1) by human NPY1 receptors. Br. J. Pharmacol. 1995, 116:2346-2348.
31. Brunstein J.D., Cline C.L., McKinney S., Thomas E. Evidence from multiplex molecular assays for complex multipathogen interactions in acute respiratory infections. J. Clin. Microbiol. 2008, 46:97-102.
32. Bursztein C., Apter A. Adolescent suicide. Curr. Opin. Psychiatry 2009, 22:1-6.
33. Caldwell C.B., Gottesman I.I. Schizophrenia-a high-risk factor for suicide: clues to risk reduction. Suicide Life Threat. Behav. 1992, 22:479-493.
34. Carroll B.J. Clinical applications of the dexamethasone suppression test for endogenous depression. Pharmacopsychiatria 1982, 15:19-25.
35. Carroll B.J. The dexamethasone suppression test for melancholia. Br. J. Psychiatry 1982, 140:292-304.
36. CDCPrevention, 2007. Web-based injury statistics query and reporting system.
37. Chen B., Dowlatshahi D., MacQueen G.M., Wang J.F., Young L.T. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol. Psychiatry 2001, 50:260-265.
38. Clapham D.E., Neer E.J. G protein beta gamma subunits. Annu. Rev. Pharmacol. Toxicol. 1997, 37:167-203.
39. Cole G., Dobkins K.R., Hansen L.A., Terry R.D., Saitoh T. Decreased levels of protein kinase C in Alzheimer brain. Brain Res. 1988, 452:165-174.
40. Conwell Y., Duberstein P.R., Cox C., Herrmann J.H., Forbes N.T., Caine E.D. Relationships of age and axis I diagnoses in victims of completed suicide: a psychological autopsy study. Am. J. Psychiatry 1996, 153:1001-1008.
41. Conwell Y., Thompson C. Suicidal behavior in elders. Psychiatr. Clin. North Am. 2008, 31:333-356.
42. Coryell W., Schlesser M. The dexamethasone suppression test and suicide prediction. Am. J. Psychiatry 2001, 158:748-753.
43. Coryell W., Schlesser M.A. Suicide and the dexamethasone suppression test in unipolar depression. Am. J. Psychiatry 1981, 138:1120-1121.
44. Coull M.A., Lowther S., Katona C.L., Horton R.W. Altered brain protein kinase C in depression: a post-mortem study. Eur. Neuropsychopharmacol. 2000, 10:283-288.
45. Cowburn R.F., Marcusson J.O., Eriksson A., Wiehager B., O'Neill C. Adenylyl cyclase activity and G-protein subunit levels in postmortem frontal cortex of suicide victims. Brain Res. 1994, 633:297-304.
46. De Paermentier F., Cheetham S.C., Crompton M.R., Katona C.L., Horton R.W. Brain beta-adrenoceptor binding sites in antidepressant-free depressed suicide victims. Brain Res. 1990, 525:71-77.
47. Dean B., Opeskin K., Pavey G., Hill C., Keks N. Changes in protein kinase C and adenylate cyclase in the temporal lobe from subjects with schizophrenia. J. Neural Transm. 1997, 104:1371-1381.
48. Dechant G., Rodriguez-Tebar A., Barde Y.A. Neurotrophin receptors. Prog. Neurobiol. 1994, 42:347-352.
49. Dowlatshahi D., MacQueen G.M., Wang J.F., Reiach J.S., Young L.T. G Protein-coupled cyclic AMP signaling in postmortem brain of subjects with mood disorders: effects of diagnosis, suicide, and treatment at the time of death. J. Neurochem. 1999, 73:1121-1126.
50. Dowlatshahi D., MacQueen G.M., Wang J.F., Young L.T. Increased temporal cortex CREB concentrations and antidepressant treatment in major depression. Lancet 1998, 352:1754-1755.
51. Dracheva S., Chin B., Haroutunian V. Altered serotonin 2C receptor RNA splicing in suicide: association with editing. Neuroreport 2008, 19:379-382.
52. Dwivedi Y., Conley R.R., Roberts R.C., Tamminga C.A., Pandey G.N. [(3)H]cAMP binding sites and protein kinase a activity in the prefrontal cortex of suicide victims. Am. J. Psychiatry 2002, 159:66-73.
53. Dwivedi Y., Pandey G.N. Adenylyl cyclase-cyclicAMP signaling in mood disorders: Role of the crucial phosphorylating enzyme protein kinase A. Neuropsychiatr. Dis. Treat. 2008, 4:161-176.
54. Dwivedi Y., Rao J.S., Rizavi H.S., Kotowski J., Conley R.R., Roberts R.C., et al. Abnormal expression and functional characteristics of cyclic adenosine monophosphate response element binding protein in postmortem brain of suicide subjects. Arch. Gen. Psychiatry 2003, 60:273-282.
55. Dwivedi Y., Rizavi H.S., Conley R.R., Roberts R.C., Tamminga C.A., Pandey G.N. mRNA and protein expression of selective alpha subunits of G proteins are abnormal in prefrontal cortex of suicide victims. Neuropsychopharmacology 2002, 27:499-517.
56. Dwivedi Y., Rizavi H.S., Conley R.R., Roberts R.C., Tamminga C.A., Pandey G.N. Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch. Gen. Psychiatry 2003, 60:804-815.
57. Dwivedi Y., Rizavi H.S., Shukla P.K., Lyons J., Faludi G., Palkovits M., et al. Protein kinase A in postmortem brain of depressed suicide victims: altered expression of specific regulatory and catalytic subunits. Biol. Psychiatry 2004, 55:234-243.
58. Ernst C., Mechawar N., Turecki G. Suicide neurobiology. Prog. Neurobiol. 2009, 89:315-333.
59. Escriba P.V., Ozaita A., Garcia-Sevilla J.A. Increased mRNA expression of alpha2A-adrenoceptors, serotonin receptors and mu-opioid receptors in the brains of suicide victims. Neuropsychopharmacology 2004, 29:1512-1521.
60. Exton J.H. Phosphoinositide phospholipases and G proteins in hormone action. Annu. Rev. Physiol. 1994, 56:349-369.
61. Fields T.A., Casey P.J. Signalling functions and biochemical properties of pertussis toxin-resistant G-proteins. Biochem. J. 1997, 321(Pt 3):561-571.
62. Finkbeiner S. Calcium regulation of the brain-derived neurotrophic factor gene. Cell. Mol. Life Sci. 2000, 57:394-401.
63. Friedman E., Hoau Yan W., Levinson D., Connell T.A., Singh H. Altered platelet protein kinase C activity in bipolar affective disorder, manic episode. Biol. Psychiatry 1993, 33:520-525.
64. Galfalvy H., Currier D., Oquendo M.A., Sullivan G., Huang Y.Y., John Mann J. Lower CSF MHPG predicts short-term risk for suicide attempt. Int. J. Neuropsychopharmacol. 2009, 12:1327-1335.
65. Garcia-Sevilla J.A., Escriba P.V., Guimon J. Imidazoline receptors and human brain disorders. Ann. N.Y. Acad. Sci. 1999, 881:392-409.
66. Garcia-Sevilla J.A., Escriba P.V., Ozaita A., La Harpe R., Walzer C., Eytan A., et al. Up-regulation of immunolabeled alpha2A-adrenoceptors, Gi coupling proteins, and regulatory receptor kinases in the prefrontal cortex of depressed suicides. J. Neurochem. 1999, 72:282-291.
67. Gilman A.G. Guanine nucleotide-binding regulatory proteins and dual control of adenylate cyclase. J. Clin. Invest. 1984, 73:1-4.
68. Gilman A.G. G proteins: transducers of receptor-generated signals. Annu. Rev. Biochem. 1987, 56:615-649.
69. Gold P.W., Goodwin F.K., Chrousos G.P. Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (1). N. Engl. J. Med. 1988, 319:348-353.
70. Reducing Suicide, A National Imperative. Committee on Pathophysiology and Prevention of Adolescent and Adult Suicide, Board on Neuroscience and Behavioral Health, Institute of Medicine of the National Academies 2002, The National Academies Press, Washington, DC. S.K. Goldsmith, T.C. Pellmar, J. Kleinman, W.E. Bunney (Eds.).
71. Gonzalez A.M., Pascual J., Meana J.J., Barturen F., del Arco C., Pazos A., et al. Autoradiographic demonstration of increased alpha 2-adrenoceptor agonist binding sites in the hippocampus and frontal cortex of depressed suicide victims. J. Neurochem. 1994, 63:256-265.
72. Goodwin R.D., Eaton W.W. Asthma, suicidal ideation, and suicide attempts: findings from the Baltimore epidemiologic catchment area follow-up. Am. J. Public Health 2005, 95:717-722.
73. Goodwin R.D., Messineo K., Bregante A., Hoven C.W., Kairam R. Prevalence of probable mental disorders among pediatric asthma patients in an inner-city clinic. J. Asthma 2005, 42:643-647.
74. Grabarek J., Raychowdhury M., Ravid K., Kent K.C., Newman P.J., Ware J.A. Identification and functional characterization of protein kinase C isozymes in platelets and HEL cells. J. Biol. Chem. 1992, 267:10011-10017.
75. Gross-Isseroff R., Dillon K.A., Fieldust S.J., Biegon A. Autoradiographic analysis of alpha 1-noradrenergic receptors in the human brain postmortem. Effect of suicide. Arch. Gen. Psychiatry 1990, 47:1049-1053.
76. Gurevich I., Tamir H., Arango V., Dwork A.J., Mann J.J., Schmauss C. Altered editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims. Neuron 2002, 34:349-356.
77. Harris E.C., Barraclough B. Excess mortality of mental disorder. Br. J. Psychiatry 1998, 173:11-53.
78. Hiroi N., Wong M.L., Licinio J., Park C., Young M., Gold P.W., et al. Expression of corticotropin releasing hormone receptors type I and type II mRNA in suicide victims and controls. Mol. Psychiatry 2001, 6:540-546.
79. Hlady W.G., Middaugh J.P. Suicides in Alaska: firearms and alcohol. Am. J. Public Health 1988, 78:179-180.
80. Holian O., Kumar R., Attar B. Apoprotein A-1 is a cofactor independent substrate of protein kinase C. Biochem. Biophys. Res. Commun. 1991, 179:599-604.
81. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 2000, 23:477-501.
82. Hopkins S.J., Rothwell N.J. Cytokines and the nervous system. I: Expression and recognition. Trends Neurosci. 1995, 18:83-88.
83. Hoyer D., Clarke D.E., Fozard J.R., Hartig P.R., Martin G.R., Mylecharane E.J., et al. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol. Rev. 1994, 46:157-203.
84. Huang E.J., Reichardt L.F. Neurotrophins: roles in neuronal development and function. Annu. Rev. Neurosci. 2001, 24:677-736.
85. Hug H., Sarre T.F. Protein kinase C isoenzymes: divergence in signal transduction?. Biochem. J. 1993, 291(Pt 2):329-343.
86. Joyce J.N., Shane A., Lexow N., Winokur A., Casanova M.F., Kleinman J.E. Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics. Neuropsychopharmacology 1993, 8:315-336.
87. Kiley S.C., Jaken S. Protein kinase C: interactions and consequences. Trends Cell. Biol. 1994, 4:223-227.
88. Klomek A.B., Marrocco F., Kleinman M., Schonfeld I.S., Gould M.S. Peer victimization, depression, and suicidiality in adolescents. Suicide Life Threat. Behav. 2008, 38:166-180.
89. Kronfol Z., Remick D.G. Cytokines and the brain: implications for clinical psychiatry. Am. J. Psychiatry 2000, 157:683-694.
90. Kurose H., Regan J.W., Caron M.G., Lefkowitz R.J. Functional interactions of recombinant alpha 2 adrenergic receptor subtypes and G proteins in reconstituted phospholipid vesicles. Biochemistry 1991, 30:3335-3341.
91. Lenox R.H., Watson D.G., Patel J., Ellis J. Chronic lithium administration alters a prominent PKC substrate in rat hippocampus. Brain Res. 1992, 570:333-340.
92. Lester D. The dexamethasone suppression test as an indicator of suicide: a meta-analysis. Pharmacopsychiatry 1992, 25:265-270.
93. Lester D. The concentration of neurotransmitter metabolites in the cerebrospinal fluid of suicidal individuals: a meta-analysis. Pharmacopsychiatry 1995, 28:45-50.
94. Lichtenberg P., Shapira B., Gillon D., Kindler S., Cooper T.B., Newman M.E., et al. Hormone responses to fenfluramine and placebo challenge in endogenous depression. Psychiatry Res. 1992, 43:137-146.
95. Lindqvist D., Janelidze S., Hagell P., Erhardt S., Samuelsson M., Minthon L., et al. Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity. Biol. Psychiatry 2009, 66:287-292.
96. Linnoila V.M., Virkkunen M. Aggression, suicidality, and serotonin. J. Clin. Psychiatry 1992, 53(Suppl.):46-51.
97. Lönqvist J.K. Psychiatric aspects of suicidal behavior: Depression. The International Handbook of Suicide and Attempted Suicide 2000, 107-120. John Wiley and Sons, Chichester, UK. K. Hawton, K. van Heeringen (Eds.).
98. Lowther S., De Paermentier F., Cheetham S.C., Crompton M.R., Katona C.L., Horton R.W. 5-HT1A receptor binding sites in post-mortem brain samples from depressed suicides and controls. J. Affect. Disord. 1997, 42:199-207.
99. Manji H.K., Bebchuk J.M., Moore G.J., Glitz D., Hasanat K.A., Chen G. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications. J. Clin. Psychiatry 1999, 60(Suppl. 2):27-39. (discussion 40-21, 113-116).
100. Manji H.K., Moore G.J., Chen G. Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness. Biol. Psychiatry 2000, 48:740-754.
101. Mann J.J. Neurobiology of suicidal behaviour. Nat. Rev. Neurosci. 2003, 4:819-828.
102. Mann J.J., McBride P.A., Brown R.P., Linnoila M., Leon A.C., DeMeo M., et al. Relationship between central and peripheral serotonin indexes in depressed and suicidal psychiatric inpatients. Arch. Gen. Psychiatry 1992, 49:442-446.
103. Mann J.J., Stanley M., McBride P.A., McEwen B.S. Increased serotonin2 and beta-adrenergic receptor binding in the frontal cortices of suicide victims. Arch. Gen. Psychiatry 1986, 43:954-959.
104. Masliah E., Cole G., Shimohama S., Hansen L., DeTeresa R., Terry R.D., et al. Differential involvement of protein kinase C isozymes in Alzheimer's disease. J. Neurosci. 1990, 10:2113-2124.
105. Matsubara S., Arora R.C., Meltzer H.Y. Serotonergic measures in suicide brain: 5-HT1A binding sites in frontal cortex of suicide victims. J. Neural Transm. Gen. Sect. 1991, 85:181-194.
106. McNamara R.K., Hyde T.M., Kleinman J.E., Lenox R.H. Expression of the myristoylated alanine-rich C kinase substrate (MARCKS) and MARCKS-related protein (MRP) in the prefrontal cortex and hippocampus of suicide victims. J. Clin. Psychiatry 1999, 60(Suppl. 2):21-26. (discussion 40-21, 113-116).
107. Meana J.J., Garcia-Sevilla J.A. Increased alpha 2-adrenoceptor density in the frontal cortex of depressed suicide victims. J. Neural Transm. 1987, 70:377-381.
108. Meltzer H.Y., Arora R.C., Baber R., Tricou B.J. Serotonin uptake in blood platelets of psychiatric patients. Arch. Gen. Psychiatry 1981, 38:1322-1326.
109. Meltzer H.Y., Lowy M.T. The serotonin hypothesis of depression. Psychopharmacology: The Third Generation of Progress 1987, Raven Press, New York. H. Meltzer (Ed.).
110. Merali Z., Du L., Hrdina P., Palkovits M., Faludi G., Poulter M.O., et al. Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA(A) receptor subunits in frontal cortical brain region. J. Neurosci. 2004, 24:1478-1485.
111. Merali Z., Kent P., Du L., Hrdina P., Palkovits M., Faludi G., et al. Corticotropin-releasing hormone, arginine vasopressin, gastrin-releasing peptide, and neuromedin B alterations in stress-relevant brain regions of suicides and control subjects. Biol. Psychiatry 2006, 59:594-602.
112. Meyerson L.R., Wennogle L.P., Abel M.S., Coupet J., Lippa A.S., Rauh C.E., et al. Human brain receptor alterations in suicide victims. Pharmacol. Biochem. Behav. 1982, 17:159-163.
113. Middlemas D.S., Lindberg R.A., Hunter T. trkB, a neural receptor protein-tyrosine kinase: evidence for a full-length and two truncated receptors. Mol. Cell. Biol. 1991, 11:143-153.
114. Moscicki E.K. Identification of suicide risk factors using epidemiologic studies. Psychiatr. Clin. N. Am. 1997, 20:499-517.
115. Muller N., Ackenheil M. Psychoneuroimmunology and the cytokine action in the CNS: implications for psychiatric disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry 1998, 22:1-33.
116. Neer E.J. Heterotrimeric G proteins: organizers of transmembrane signals. Cell 1995, 80:249-257.
117. Nemeroff C.B. The corticotropin-releasing factor (CRF) hypothesis of depression: new findings and new directions. Mol. Psychiatry 1996, 1:336-342.
118. Nemeroff C.B., Owens M.J., Bissette G., Andorn A.C., Stanley M. Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims. Arch. Gen. Psychiatry 1988, 45:577-579.
119. Nibuya M., Morinobu S., Duman R.S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J. Neurosci. 1995, 15:7539-7547.
120. Nibuya M., Nestler E.J., Duman R.S. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J. Neurosci. 1996, 16:2365-2372.
121. Nichols M., Weih F., Schmid W., DeVack C., Kowenz-Leutz E., Luckow B., et al. Phosphorylation of CREB affects its binding to high and low affinity sites: implications for cAMP induced gene transcription. EMBO J. 1992, 11:3337-3346.
122. Nishizuka Y. The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 1988, 334:661-665.
123. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 1992, 258:607-614.
124. Nishizuka Y. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J. 1995, 9:484-496.
125. Nordstrom P., Samuelsson M., Asberg M., Traskman-Bendz L., Aberg-Wistedt A., Nordin C., et al. CSF 5-HIAA predicts suicide risk after attempted suicide. Suicide Life Threat. Behav. 1994, 24:1-9.
126. Norman W.H., Brown W.A., Miller I.W., Keitner G.I., Overholser J.C. The dexamethasone suppression test and completed suicide. Acta Psychiatr. Scand. 1990, 81:120-125.
127. Ono Y., Fujii T., Ogita K., Kikkawa U., Igarashi K., Nishizuka Y. The structure, expression, and properties of additional members of the protein kinase C family. J. Biol. Chem. 1988, 263:6927-6932.
128. Ono Y., Fujii T., Ogita K., Kikkawa U., Igarashi K., Nishizuka Y. Protein kinase C zeta subspecies from rat brain: its structure, expression, and properties. Proc. Natl. Acad. Sci. U.S.A. 1989, 86:3099-3103.
129. Ordway G.A., Smith K.S., Haycock J.W. Elevated tyrosine hydroxylase in the locus coeruleus of suicide victims. J. Neurochem. 1994, 62:680-685.
130. Ordway G.A., Widdowson P.S., Smith K.S., Halaris A. Agonist binding to alpha 2-adrenoceptors is elevated in the locus coeruleus from victims of suicide. J. Neurochem. 1994, 63:617-624.
131. Ostroff R., Giller E., Bonese K., Ebersole E., Harkness L., Mason J. Neuroendocrine risk factors of suicidal behavior. Am. J. Psychiatry 1982, 139:1323-1325.
132. Owens M.J., Nemeroff C.B. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol. Rev. 1991, 43:425-473.
133. Owens M.J., Nemeroff C.B. The role of corticotropin-releasing factor in the pathophysiology of affective and anxiety disorders: laboratory and clinical studies. Ciba Found Symp. 1993, 172:296-308. (discussion 308-216).
134. Pacheco M.A., Stockmeier C., Meltzer H.Y., Overholser J.C., Dilley G.E., Jope R.S. Alterations in phosphoinositide signaling and G-protein levels in depressed suicide brain. Brain Res. 1996, 723:37-45.
135. Pandey G.N. Corticotropin releasing factor and glucocorticoid receptors in the postmortem brain of teenage suicide victims. Biol. Psychiatry 2010, 67:196S.
136. Pandey G.N., Dwivedi Y., Pandey S.C., Conley R.R., Roberts R.C., Tamminga C.A. Protein kinase C in the postmortem brain of teenage suicide victims. Neurosci. Lett. 1997, 228:111-114.
137. Pandey G.N., Dwivedi Y., Pandey S.C., Teas S.S., Conley R.R., Roberts R.C., et al. Low phosphoinositide-specific phospholipase C activity and expression of phospholipase C beta1 protein in the prefrontal cortex of teenage suicide subjects. Am. J. Psychiatry 1999, 156:1895-1901.
138. Pandey G.N., Dwivedi Y., Ren X., Rizavi H.S., Faludi G., Sarosi A., et al. Regional distribution and relative abundance of serotonin(2c) receptors in human brain: effect of suicide. Neurochem. Res. 2006, 31:167-176.
139. Pandey G.N., Dwivedi Y., Ren X., Rizavi H.S., Mondal A.C., Shukla P.K., et al. Brain region specific alterations in the protein and mRNA levels of protein kinase A subunits in the post-mortem brain of teenage suicide victims. Neuropsychopharmacology 2005, 30:1548-1556.
140. Pandey G.N., Dwivedi Y., Ren X., Rizavi H.S., Roberts R.C., Conley R.R. Cyclic AMP response element-binding protein in post-mortem brain of teenage suicide victims: specific decrease in the prefrontal cortex but not the hippocampus. Int. J. Neuropsychopharmacol. 2007, 10:621-629.
141. Pandey G.N., Dwivedi Y., Ren X., Rizavi H.S., Roberts R.C., Conley R.R., et al. Altered expression and phosphorylation of myristoylated alanine-rich C kinase substrate (MARCKS) in postmortem brain of suicide victims with or without depression. J. Psychiatr. Res. 2003, 37:421-432.
142. Pandey G.N., Dwivedi Y., Rizavi H.S., Ren X., Conley R.R. Decreased catalytic activity and expression of protein kinase C isozymes in teenage suicide victims: a postmortem brain study. Arch. Gen. Psychiatry 2004, 61:685-693.
143. Pandey G.N., Dwivedi Y., Rizavi H.S., Ren X., Pandey S.C., Pesold C., et al. Higher expression of serotonin 5-HT(2A) receptors in the postmortem brains of teenage suicide victims. Am. J. Psychiatry 2002, 159:419-429.
144. Pandey G.N., Dwivedi Y., SridharaRao J., Ren X., Janicak P.G., Sharma R. Protein kinase C and phospholipase C activity and expression of their specific isozymes is decreased and expression of MARCKS is increased in platelets of bipolar but not in unipolar patients. Neuropsychopharmacology 2002, 26:216-228.
145. Pandey G.N., Pandey S.C., Dwivedi Y., Sharma R.P., Janicak P.G., Davis J.M. Platelet serotonin-2A receptors: a potential biological marker for suicidal behavior. Am. J. Psychiatry 1995, 152:850-855.
146. Pandey G.N., Pandey S.C., Janicak P.G., Marks R.C., Davis J.M. Platelet serotonin-2 receptor binding sites in depression and suicide. Biol. Psychiatry 1990, 28:215-222.
147. Pariante C.M., Miller A.H. Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol. Psychiatry 2001, 49:391-404.
148. Perlman W.R., Webster M.J., Kleinman J.E., Weickert C.S. Reduced glucocorticoid and estrogen receptor alpha messenger ribonucleic acid levels in the amygdala of patients with major mental illness. Biol. Psychiatry 2004, 56:844-852.
149. Perry E.K., Marshall E.F., Blessed G., Tomlinson B.E., Perry R.H. Decreased imipramine binding in the brains of patients with depressive illness. Br. J. Psychiatry 1983, 142:188-192.
150. Raadsheer F.C., Hoogendijk W.J., Stam F.C., Tilders F.J., Swaab D.F. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology 1994, 60:436-444.
151. Rausch J.L., Janowsky D.S., Risch S.C., Huey L.Y. A kinetic analysis and replication of decreased platelet serotonin uptake in depressed patients. Psychiatry Res. 1986, 19:105-112.
152. Reul J.M., de Kloet E.R. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 1985, 117:2505-2511.
153. Rhee S.G., Choi K.D. Regulation of inositol phospholipid-specific phospholipase C isozymes. J. Biol. Chem. 1992, 267:12393-12396.
154. Riabowol K.T., Fink J.S., Gilman M.Z., Walsh D.A., Goodman R.H., Feramisco J.R. The catalytic subunit of cAMP-dependent protein kinase induces expression of genes containing cAMP-responsive enhancer elements. Nature 1988, 336:83-86.
155. Roy A., Pickar D., Linnoila M., Doran A.R., Ninan P., Paul S.M. Cerebrospinal fluid monoamine and monoamine metabolite concentrations in melancholia. Psychiatry Res. 1985, 15:281-292.
156. Secunda S.K., Cross C.K., Koslow S., Katz M.M., Kocsis J., Maas J.W., et al. Biochemistry and suicidal behavior in depressed patients. Biol. Psychiatry 1986, 21:756-767.
157. Shearman M.S., Naor Z., Kikkawa U., Nishizuka Y. Differential expression of multiple protein kinase C subspecies in rat central nervous tissue. Biochem. Biophys. Res. Commun. 1987, 147:911-919.
158. Shelton R.C., Sanders-Bush E., Manier D.H., Lewis D.A. Elevated 5-HT 2A receptors in postmortem prefrontal cortex in major depression is associated with reduced activity of protein kinase A. Neuroscience 2009, 158:1406-1415.
159. Sher L., Carballo J.J., Grunebaum M.F., Burke A.K., Zalsman G., Huang Y.Y., et al. A prospective study of the association of cerebrospinal fluid monoamine metabolite levels with lethality of suicide attempts in patients with bipolar disorder. Bipolar Disord. 2006, 8:543-550.
160. Shimohama S., Narita M., Matsushima H., Kimura J., Kameyama M., Hagiwara M., et al. Assessment of protein kinase C isozymes by two-site enzyme immunoassay in human brains and changes in Alzheimer's disease. Neurology 1993, 43:1407-1413.
161. Simon M.I., Strathmann M.P., Gautam N. Diversity of G proteins in signal transduction. Science 1991, 252:802-808.
162. Singh G.K., Kochanek K.D., MacDorman M.F. Advance report of final mortality statistics, 1994. NCHS Monthly 1996, 45(3). (Supplement: National Center for Health Statistics).
163. Skalhegg B.S., Tasken K. Specificity in the cAMP/PKA signaling pathway. Differential expression,regulation, and subcellular localization of subunits of PKA. Front. Biosci. 2000, 5:D678-693.
164. Stanley M., Mann J.J. Increased serotonin-2 binding sites in frontal cortex of suicide victims. Lancet 1983, 1:214-216.
165. Stanley M., Virgilio J., Gershon S. Tritiated imipramine binding sites are decreased in the frontal cortex of suicides. Science 1982, 216:1337-1339.
166. Steiner J., Bielau H., Brisch R., Danos P., Ullrich O., Mawrin C., et al. Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. J. Psychiatr. Res. 2008, 42:151-157.
167. Stockmeier C.A., Howley E., Shi X., Sobanska A., Clarke G., Friedman L., et al. Antagonist but not agonist labeling of serotonin-1A receptors is decreased in major depressive disorder. J. Psychiatr. Res. 2009, 43:887-894.
168. Stockmeier C.A., Shapiro L.A., Dilley G.E., Kolli T.N., Friedman L., Rajkowska G. Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity. J. Neurosci. 1998, 18:7394-7401.
169. Stokes C.E., Hawthorne J.N. Reduced phosphoinositide concentrations in anterior temporal cortex of Alzheimer-diseased brains. J. Neurochem. 1987, 48:1018-1021.
170. Tamas Z., Kovacs M., Gentzler A.L., Tepper P., Gadoros J., Kiss E., et al. The relations of temperament and emotion self-regulation with suicidal behaviors in a clinical sample of depressed children in Hungary. J. Abnorm. Child Psychol. 2007, 35:640-652.
171. Tanaka C., Nishizuka Y. The protein kinase C family for neuronal signaling. Annu. Rev. Neurosci. 1994, 17:551-567.
172. Thoenen H. Neurotrophins and neuronal plasticity. Science 1995, 270:593-598.
173. Tonelli L.H., Stiller J., Rujescu D., Giegling I., Schneider B., Maurer K., et al. Elevated cytokine expression in the orbitofrontal cortex of victims of suicide. Acta Psychiat. Scand. 2008, 117:198-206.
174. Tripodianakis J., Markianos M., Sarantidis D., Agouridaki M. Biogenic amine turnover and serum cholesterol in suicide attempt. Eur. Arch. Psychiatry Clin. Neurosci. 2002, 252:38-43.
175. Underwood M.D., Mann J.J., Arango V. Serotonergic and noradrenergic neurobiology of alcoholic suicide. Alcohol Clin. Exp. Res. 2004, 28:57S-69S.
176. van Heeringen C., Audenaert K., Van Laere K., Dumont F., Slegers G., Mertens J., et al. Prefrontal 5-HT2a receptor binding index, hopelessness and personality characteristics in attempted suicide. J. Affect. Disord. 2003, 74:149-158.
177. Van Praag H.M. Depression, suicide and the metabolism of serotonin in the brain. J. Affect. Disord. 1982, 4:275-290.
178. Van Praag H.M. CSF 5-HIAA and suicide in non-depressed schizophrenics. Lancet 1983, 2:977-978.
179. Wang L., Watson D.G., Lenox R.H. Myristoylation alters retinoic acid-induced down-regulation of MARCKS in immortalized hippocampal cells. Biochem. Biophys. Res. Commun. 2000, 276:183-188.
180. Watson D.G., Wainer B.H., Lenox R.H. Phorbol ester- and retinoic acid-induced regulation of the protein kinase C substrate MARCKS in immortalized hippocampal cells. J. Neurochem. 1994, 63:1666-1674.
181. Webster M.J., Knable M.B., O'Grady J., Orthmann J., Weickert C.S. Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders. Mol. Psychiatry 2002, 7:985-994. 924.
182. Weissman M.M., Klerman G.L., Markowitz J.S., Ouellette R. Suicidal ideation and suicide attempts in panic disorder and attacks. N. Engl. J. Med. 1989, 321:1209-1214.
183. Westrin A. Stress system alterations and mood disorders in suicidal patients. A review. Biomed. Pharmacother. 2000, 54:142-145.
184. Xie H., Rothstein T.L. Protein kinase C mediates activation of nuclear cAMP response element-binding protein (CREB) in B lymphocytes stimulated through surface Ig. J. Immunol. 1995, 154:1717-1723.
185. Yamada S., Yamamoto M., Ozawa H., Riederer P., Saito T. Reduced phosphorylation of cyclic AMP-responsive element binding protein in the postmortem orbitofrontal cortex of patients with major depressive disorder. J. Neural Transm. 2003, 110:671-680.
186. Yerevanian B.I., Feusner J.D., Koek R.J., Mintz J. The dexamethasone suppression test as a predictor of suicidal behavior in unipolar depression. J. Affect. Disord. 2004, 83:103-108.
187. Yerevanian B.I., Olafsdottir H., Milanese E., Russotto J., Mallon P., Baciewicz G., et al. Normalization of the dexamethasone suppression test at discharge from hospital. Its prognostic value. J. Affect. Disord. 1983, 5:191-197.
188. Zalsman G., Levy T., Shoval G. Interaction of child and family psychopathology leading to suicidal behavior. Psychiatr. Clin. N. Am. 2008, 31:237-246.